Anand Devaraj

2.9k total citations · 1 hit paper
18 papers, 1.7k citations indexed

About

Anand Devaraj is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Rheumatology. According to data from OpenAlex, Anand Devaraj has authored 18 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 3 papers in Rheumatology. Recurrent topics in Anand Devaraj's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers), Sarcoidosis and Beryllium Toxicity Research (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). Anand Devaraj is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers), Sarcoidosis and Beryllium Toxicity Research (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers). Anand Devaraj collaborates with scholars based in United Kingdom, United States and Italy. Anand Devaraj's co-authors include Athol U. Wells, Yoshikazu Inoue, Vincent Cottin, Simon Walsh, Luca Richeldi, Rozsa Schlenker‐Herceg, Emmanuelle Clerisme-Beaty, Rainer-Georg Goeldner, Kevin K. Brown and Martin Kolb and has published in prestigious journals such as New England Journal of Medicine, European Respiratory Journal and Thorax.

In The Last Decade

Anand Devaraj

17 papers receiving 1.7k citations

Hit Papers

Nintedanib in Progressive Fibrosing Interstitial Lung Dis... 2019 2026 2021 2023 2019 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
    2019 1.3k citations Kevin R. Flaherty, Athol U. Wells et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anand Devaraj United Kingdom 9 1.5k 638 411 282 195 18 1.7k
Julie Dawson United Kingdom 14 1.0k 0.7× 591 0.9× 277 0.7× 300 1.1× 500 2.6× 31 1.3k
Manuel Quaresma Germany 20 2.8k 1.8× 1.2k 1.9× 668 1.6× 419 1.5× 402 2.1× 64 3.1k
P. Pantelidis United Kingdom 12 866 0.6× 254 0.4× 504 1.2× 259 0.9× 81 0.4× 14 1.0k
Keishi Sugino Japan 18 820 0.5× 226 0.4× 75 0.2× 209 0.7× 190 1.0× 112 1.1k
Yimy F. Medina Colombia 6 529 0.3× 317 0.5× 145 0.4× 169 0.6× 396 2.0× 29 761
Yutaka Hirasawa Japan 13 539 0.4× 196 0.3× 62 0.2× 136 0.5× 79 0.4× 27 874
Keishi Oda Japan 16 536 0.4× 182 0.3× 39 0.1× 139 0.5× 60 0.3× 36 701
Bertrand Dunogué France 17 337 0.2× 138 0.2× 117 0.3× 103 0.4× 375 1.9× 36 857
Yueren Zhou United States 12 416 0.3× 107 0.2× 61 0.1× 297 1.1× 35 0.2× 29 988
Norihiro Kaneko Japan 12 256 0.2× 188 0.3× 46 0.1× 210 0.7× 61 0.3× 57 698

Countries citing papers authored by Anand Devaraj

Since Specialization
Citations

This map shows the geographic impact of Anand Devaraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anand Devaraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anand Devaraj more than expected).

Fields of papers citing papers by Anand Devaraj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anand Devaraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anand Devaraj. The network helps show where Anand Devaraj may publish in the future.

Co-authorship network of co-authors of Anand Devaraj

This figure shows the co-authorship network connecting the top 25 collaborators of Anand Devaraj. A scholar is included among the top collaborators of Anand Devaraj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anand Devaraj. Anand Devaraj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Feary, Johanna, Anand Devaraj, Matthew Burton, et al.. (2024). Artificial stone silicosis: a UK case series. Thorax. 79(10). 979–981. 10 indexed citations
2.
Rao, Roopa S, Shankargouda Patil, Dominic Augustine, et al.. (2022). An Unusual Case of Intravascular Oral Nodular Fasciitis: A Case Report/Review. World Journal of Dentistry. 13(4). 412–416. 1 indexed citations
3.
Flaherty, Kevin R., Athol U. Wells, Vincent Cottin, et al.. (2021). Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial. European Respiratory Journal. 59(3). 2004538–2004538. 65 indexed citations
4.
5.
Koschel, Dirk, Vincent Cottin, Anand Devaraj, et al.. (2020). Nintedanib in patients with chronic fibrosing Interstitial lung diseases with progressive phenotype: the INBUILD trial*. Pneumologie. 2 indexed citations
6.
Devaraj, Anand. (2020). A Case of Dupilumab Related Eosinophilic Pneumonia. A4942–A4942. 3 indexed citations
7.
Flaherty, Kevin R., Athol U. Wells, Vincent Cottin, et al.. (2020). Effects of nintedanib on progression of ILD in patients with fibrosing ILDs and a progressive phenotype: further analyses of the INBUILD trial. 4578–4578. 1 indexed citations
8.
Flaherty, Kevin R., Athol U. Wells, Vincent Cottin, et al.. (2019). Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. New England Journal of Medicine. 381(18). 1718–1727. 1333 indexed citations breakdown →
9.
Jacob, Joseph, Cátherine M. Owens, Alan S. Brody, et al.. (2019). Evaluation of inter-observer variation for computed tomography identification of childhood interstitial lung disease. ERJ Open Research. 5(3). 100–2019. 3 indexed citations
10.
Flaherty, Kevin R., Athol U. Wells, Emmanuelle Clerisme-Beaty, et al.. (2019). Characteristics of Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) in the INBUILD Trial of Nintedanib. A5627–A5627. 4 indexed citations
11.
Robbie, Hasti, Athol U. Wells, Joseph Jacob, et al.. (2019). Visual and Automated CT Measurements of Lung Volume Loss in Idiopathic Pulmonary Fibrosis. American Journal of Roentgenology. 213(2). 318–324. 30 indexed citations
12.
Flaherty, Kevin R., Athol U. Wells, Vincent Cottin, et al.. (2019). Nintedanib in patients with chronic fibrosing interstitial lung diseases with progressive phenotype: the INBUILD trial. RCT1881–RCT1881. 4 indexed citations
13.
Flaherty, Kevin, Kevin M. Brown, Athol U. Wells, et al.. (2017). Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease. BMJ Open Respiratory Research. 4(1). e000212–e000212. 134 indexed citations
14.
George, Peter M., Anand Devaraj, Andrew G. Nicholson, & Felix Chua. (2016). An emerging interstitial lung disease. The Lancet Respiratory Medicine. 4(9). 762–762. 2 indexed citations
15.
Viola, Patrizia, Katherine Vroobel, Anand Devaraj, et al.. (2016). Follicular dendritic cell tumour/sarcoma: a commonly misdiagnosed tumour in the thorax. Histopathology. 69(5). 752–761. 12 indexed citations
16.
Devaraj, Anand. (2014). Imaging: how to recognise idiopathic pulmonary fibrosis. European Respiratory Review. 23(132). 215–219. 33 indexed citations
17.
Griffin, Nyree, Anand Devaraj, Peter Goldstraw, et al.. (2008). CT and histopathological correlation of congenital cystic pulmonary lesions: a common pathogenesis?. Clinical Radiology. 63(9). 995–1005. 35 indexed citations
18.
Devaraj, Anand, et al.. (2002). Interaction between warfarin and topical miconazole cream. BMJ. 325(7355). 77–77. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julie Dawson Breakdown of academic impact, for papers by Manuel Quaresma Breakdown of academic impact, for papers by P. Pantelidis Breakdown of academic impact, for papers by Keishi Sugino Breakdown of academic impact, for papers by Yimy F. Medina Breakdown of academic impact, for papers by Yutaka Hirasawa Breakdown of academic impact, for papers by Keishi Oda Breakdown of academic impact, for papers by Bertrand Dunogué Breakdown of academic impact, for papers by Yueren Zhou Breakdown of academic impact, for papers by Norihiro Kaneko
Rankless by CCL
2026